Description A global clinical research study assessing the effectiveness and safety of an investigational medication designed to slow the progression of early Alzheimer’s disease.The ENGAGE study is split into two phases: a placebo-controlled phase, and an optional long-term extension phase.In the placebo-controlled phase, eligible participants will...